Skip to main content

24-05-2017 | Non-small-cell lung cancer | Article

Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial

Shaverdian N et al. Lancet Oncol 2017; 18(7): 895-903. doi:10.1016/S1470-2045(17)30380-7

Please log in to get access to this content

Related topics